GUIYANG XINTIAN PHARMACEUTICAL CO.,LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.44 CNY | +0.53% |
|
+2.33% | -8.19% |
| Sales 2024 * | 1.06B 147M 12.24B | Sales 2025 * | 1.19B 165M 13.73B | Capitalization | 2.63B 364M 30.33B |
|---|---|---|---|---|---|
| Net income 2024 * | 101M 13.95M 1.16B | Net income 2025 * | 116M 16.02M 1.34B | EV / Sales 2024 * | 2.48 x |
| Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 2.21 x |
| P/E ratio 2024 * |
26
x | P/E ratio 2025 * |
22.9
x | Employees | 1,958 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 57.4% |
More Fundamentals
* Assessed data
More news
| 1 day | +0.53% | ||
| 1 week | +2.33% | ||
| Current month | -8.41% | ||
| 1 month | -9.06% | ||
| 3 months | +6.32% | ||
| 6 months | -4.83% | ||
| Current year | -8.19% |
1 week
11.08
11.66
1 month
10.3913.28
Current year
7.5914.33
1 year
7.5915.24
3 years
7.5920.12
5 years
7.0220.12
10 years
6.6320.12
| Managers | Title | Age | Since |
|---|---|---|---|
Da Lun Dong
CEO | Chief Executive Officer | 60 | 11/95/11 |
Zhi Hui Zeng
DFI | Director of Finance/CFO | 51 | 01/18/01 |
Zhong Lei He
BRD | Director/Board Member | 47 | 01/21/01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Da Lun Dong
CEO | Chief Executive Officer | 60 | 11/95/11 |
Jin Hua Wang
BRD | Director/Board Member | 57 | 11/95/11 |
Jue Rong Chen
PRN | Corporate Officer/Principal | 55 | 01/06/01 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/24/26 | 11.44 | +0.53% | 2,781,385 |
| 25/24/25 | 11.38 | +0.26% | 1,776,310 |
| 24/24/24 | 11.35 | -1.39% | 2,590,856 |
| 23/24/23 | 11.51 | +3.04% | 2,927,340 |
| 22/24/22 | 11.17 | -0.09% | 2,112,016 |
End-of-day quote Shenzhen S.E., April 26, 2024
More quotes
Guiyang Xintian Pharmaceutical Co., Ltd. is a China-based company principally engaged in the research, development, production and sales of Chinese patent drugs. The Company manufactures its products in the forms of capsules, mixture, granules, syrup, gel and tablets. The Companyâs main products include Ningmitai Capsule, Kuntai Capsule, Kushen Gel and Xiaokucao Oral Liquid .The Company distributes its products in the domestic market.
Sector
Pharmaceuticals
Calendar
13/05/2024
- Annual General Meeting
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
11.44
Average target price
-
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -8.19% | 363M | |
| +4.09% | 70.44B | |
| +10.97% | 8.94B | |
| -16.83% | 4.75B | |
| +43.48% | 4.5B | |
| +3.20% | 3.85B | |
| +21.10% | 2.38B | |
| -21.36% | 2.34B | |
| -29.67% | 2.2B | |
| +8.38% | 1.96B |
- Stock Market
- Equities
- 002873 Stock
